Hoba Therapeutics ApS — Credit Rating and Financial Key Figures
CVR number: 38231170
Ole Maaløes Vej 3, 2200 København N
md@hobatherapeutics.com
www.hobatherapeutics.com
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Other operating income | 1 214.01 | 678.38 | 7 334.64 | 9 692.96 | |
| External services | -4 707.54 | -7 860.07 | -16 764.36 | -30 553.16 | |
| Gross profit | 838.89 | -3 493.53 | -7 181.70 | -9 429.73 | -20 860.21 |
| Employee benefit expenses | -2 121.16 | -2 899.56 | -2 997.22 | -5 980.41 | -9 789.58 |
| Total depreciation | -11.47 | -3.98 | -2.98 | ||
| EBIT | -1 293.74 | -6 397.07 | -10 181.90 | -15 410.14 | -30 649.79 |
| Other financial income | 15.96 | 12.82 | 663.89 | ||
| Other financial expenses | - 753.61 | -1 506.73 | -2 523.80 | -2 629.22 | -3 320.82 |
| Pre-tax profit | -2 047.35 | -7 887.84 | -12 705.70 | -18 026.53 | -33 306.72 |
| Income taxes | 465.24 | 1 387.75 | 1 807.03 | 4 096.22 | 5 500.00 |
| Net earnings | -1 582.11 | -6 500.09 | -10 898.67 | -13 930.31 | -27 806.72 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Development expenditure | 14 218.72 | ||||
| Intangible assets total | 14 218.72 | ||||
| Machinery and equipment | 6.96 | 2.98 | |||
| Tangible assets total | 6.96 | 2.98 | |||
| Investments total | |||||
| Non-current other receivables | 26.25 | 26.25 | 26.77 | 65.35 | 58.66 |
| Long term receivables total | 26.25 | 26.25 | 26.77 | 65.35 | 58.66 |
| Inventories total | |||||
| Prepayments and accrued income | 26.40 | 1 938.81 | |||
| Current other receivables | 175.26 | 701.82 | 16 638.03 | 5 669.99 | 786.97 |
| Current deferred tax assets | 1 189.24 | 1 387.75 | 1 807.03 | 4 096.22 | 5 500.00 |
| Short term receivables total | 1 364.51 | 2 089.57 | 18 445.06 | 9 792.61 | 8 225.78 |
| Cash and bank deposits | 8 692.91 | 14 023.24 | 1 174.47 | 5 429.99 | 83 191.42 |
| Cash and cash equivalents | 8 692.91 | 14 023.24 | 1 174.47 | 5 429.99 | 83 191.42 |
| Balance sheet total (assets) | 24 309.36 | 16 142.04 | 19 646.30 | 15 287.95 | 91 475.85 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 315.38 | 315.38 | 315.38 | 315.38 | 2 373.60 |
| Other reserves | 11 090.60 | ||||
| Retained earnings | 304.45 | -1 891.54 | -8 391.63 | -19 290.30 | 94 503.31 |
| Profit of the financial year | -1 582.11 | -6 500.09 | -10 898.67 | -13 930.31 | -27 806.72 |
| Shareholders equity total | 10 128.33 | -8 076.24 | -18 974.92 | -32 905.23 | 69 070.19 |
| Provisions | 2 514.00 | ||||
| Non-current loans from credit institutions | 10 906.91 | 23 192.01 | 36 986.08 | 11 059.19 | 13 201.84 |
| Non-current accruals and deferred income | 287.70 | ||||
| Non-current other liabilities | 51.20 | 98.07 | |||
| Non-current liabilities total | 11 245.80 | 23 290.08 | 36 986.08 | 11 059.19 | 13 201.84 |
| Current loans from credit institutions | 28 458.98 | ||||
| Current trade creditors | 254.50 | 683.89 | 1 274.10 | 1 429.84 | 7 317.03 |
| Other non-interest bearing current liabilities | 166.73 | 244.32 | 361.04 | 518.73 | 742.34 |
| Accruals and deferred income | 6 726.44 | 1 144.47 | |||
| Current liabilities total | 421.23 | 928.21 | 1 635.14 | 37 133.99 | 9 203.83 |
| Balance sheet total (liabilities) | 24 309.36 | 16 142.04 | 19 646.30 | 15 287.95 | 91 475.85 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.